Key facts
- Notable investors include American Gastroenterological Association, Good Company (Israel), Maccabee Ventures, P5 Health Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Protego Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Protego Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Protego Health
Developer of an artificial intelligence-powered platform designed to prevent and appeal denied medical claims in real time. The company offers automated claim editing, real-time policy referencing, and rapid appeal generation, enabling healthcare billing teams to reduce revenue loss and resolve denials with greater speed and accuracy.
- Sector
- Information Technology
- HQ
- Albany, NY, United States
- Founded
- 2023
- Employees
- 20
- Website
- protegohealth.ai/
- Ownership
- Privately Held (backing)
Protego Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Protego Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Protego Health in its N-PORT filings yet. We sweep new filings monthly.